Abstract
Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
AUTM (2005) AUTM U.S. Licensing Survey: FY 2004. (Survey summary of the AUTM U.S. Licensing Survey: FY 2004)
Ernst&Young (2006) Beyond Borders: Global Biotechnology Report 2006
Lehman Brothers (2003) Assessing Patent Risk and Company-specific Exposure to Generics, 2003-2007e
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bogdan, D.B., Villiger, R. (2010). Introduction. In: Valuation in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-10820-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-10820-4_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-10819-8
Online ISBN: 978-3-642-10820-4
eBook Packages: Business and EconomicsEconomics and Finance (R0)